Cognitive Behavioral Therapy for Post-Traumatic Headache
Trial Summary
What is the purpose of this trial?
Posttraumatic headache (PTH) is a common and highly disabling consequence of traumatic brain injury (TBI) in U.S. military service members and veterans. Cognitive Behavioral Therapy for PTH has been shown to significantly improve disability outcomes in veterans with persistent PTH when delivered in-person. Telemedicine platforms can dramatically increase access to evidence-based care. However, whether CBT for PTH retains its effectiveness when delivered through a telemedicine platform has yet to be established. The purpose of this 3-arm randomized clinical trial is to compare Clinic-based Cognitive-Behavioral Therapy (CCBT) to Telemedicine-based Cognitive Behavioral Therapy (TCBT) and to treatment as usual (TAU) in 525 service members and veterans with chronic posttraumatic headaches (PTH) at 4 VA medical centers and 3 military treatment facilities across the U.S. Participants will be assessed for headache-related disability, headache experience, and psychiatric comorbidities across multiple time points.
Do I need to stop my current medications for this trial?
The trial does not specify if you need to stop your current medications. However, you must be stable on your headache medication, meaning no changes in prescriptions in the past 4 weeks.
What data supports the idea that Cognitive Behavioral Therapy for Post-Traumatic Headache is an effective treatment?
The available research shows that Cognitive Behavioral Therapy (CBT) is considered a strong treatment option for preventing headaches, including post-traumatic headaches. It is mentioned alongside other behavioral therapies like biofeedback and relaxation as effective methods. Although specific data on CBT for post-traumatic headaches is limited, its success in treating other types of headaches suggests it can be beneficial. Compared to acupuncture, which is also used for post-traumatic headaches but lacks thorough evaluation, CBT has more established evidence supporting its effectiveness.12345
What safety data exists for Cognitive Behavioral Therapy for Post-Traumatic Headache?
The systematic review titled 'Behavioral Therapies and Mind-Body Interventions for Posttraumatic Headache and Post-Concussive Symptoms' suggests that cognitive behavioral therapy (CBT) is a Level-A evidence-based treatment for headache prevention, indicating its safety and efficacy. Additionally, the randomized controlled trial 'Cognitive behavioural treatment for the chronic post-traumatic headache patient' evaluates the effects of CBT on headache, pain perception, psychological symptoms, and quality of life, providing further safety data for this treatment.12367
Is Cognitive Behavioral Therapy a promising treatment for post-traumatic headache?
Yes, Cognitive Behavioral Therapy (CBT) is a promising treatment for post-traumatic headache. Research shows that behavioral therapies like CBT are effective in preventing headaches and improving quality of life for those with chronic post-traumatic headache. These therapies help manage pain and psychological symptoms, making them a valuable option for treatment.12568
Research Team
Donald D McGeary, PhD
Principal Investigator
The University of Texas Health Science Center at San Antonio
Eligibility Criteria
This trial is for U.S. military service members and veterans aged 18-70 with chronic posttraumatic headaches (PTH) that started after a mild traumatic brain injury (mTBI). Participants should have significant headache-related disability, stable headache medication use, and meet specific criteria for PTH. They must be able to speak English at a 6th grade level, not have certain psychiatric or cognitive impairments, or other conditions that could affect treatment.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Clinic-based CBT, Telemedicine-based CBT, or Treatment As Usual for posttraumatic headache over 8 sessions
Follow-up
Participants are monitored for headache-related disability, anxiety, PTSD, and depressive symptoms
Treatment Details
Interventions
- Cognitive Behavioral Therapy for Posttraumatic Headache (Behavioral Intervention)
- Telemedicine-based Cognitive Behavioral Therapy (TCBT) ()
- Treatment as Usual ()
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center at San Antonio
Lead Sponsor
Dr. Andrew Masica
The University of Texas Health Science Center at San Antonio
Chief Medical Officer
MD from Indiana University School of Medicine
Dr. Taylor Eighmy
The University of Texas Health Science Center at San Antonio
Acting President
PhD in Civil Engineering from the University of New Hampshire
Brooke Army Medical Center
Collaborator
Col. Mark Stackle
Brooke Army Medical Center
Chief Executive Officer since 2024
MD
Col. Sean Hipp
Brooke Army Medical Center
Chief Medical Officer since 2024
MD
C.R.Darnall Army Medical Center
Collaborator
Desmond Doss Health Clinic, Schofield Barracks
Collaborator
Minneapolis Veterans Affairs Medical Center
Collaborator
South Texas Veterans Health Care System
Collaborator
VA Palo Alto Health Care System
Collaborator
Jean J. Gurga
VA Palo Alto Health Care System
Medical Center Director since 2023
Master's degree in Occupational Therapy from Tufts University, Bachelor's degree in Business Economics from Mills College
Rina N. Shah
VA Palo Alto Health Care System
Chief of Staff
MD, FACP
Walter Reed National Military Medical Center
Collaborator
Melissa C. Austin
Walter Reed National Military Medical Center
Chief Executive Officer since 2020
MD from University of Colorado Health Sciences Center
Melissa C. Austin
Walter Reed National Military Medical Center
Chief Medical Officer since 2020
MD, Board Certified in Anatomic and Clinical Pathology
Harvard University
Collaborator
Dr. Christopher Anzalone
Harvard University
Chief Executive Officer since 2007
PhD in Biology from UCLA
Dr. Perry
Harvard University
Chief Medical Officer since 2011
MD from Albert Einstein College of Medicine, MPH from Harvard University
University of California, Los Angeles
Collaborator
Dr. Thomas Rando
University of California, Los Angeles
Chief Medical Officer since 2023
MD from UCLA
Amir Naiberg
University of California, Los Angeles
Chief Executive Officer since 2024
JD from UCLA